Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?-Reference-Cited by-同舟云学术

Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

Published:2008-07 Issue:1 Volume:42 Page:23-28
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Ruiz-Argüelles G J,Tarin-Arzaga L C,Gonzalez-Carrillo M L,Gutierrez-Riveroll K I,Rangel-Malo R,Gutiérrez-Aguirre C H,Cantú-Rodríguez O G,Gómez-Almaguer D,Giralt S

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt200890.pdf

Reference33 articles.

1. Goldman JM . Advances in CML. Clin Adv Hematol Oncol 2007; 5: 270–272.

2. Gómez-Almaguer D . Leucemias crónicas. In: Ruiz-Argüelles GJ (ed). Fundamentos de Hematología, 3rd edn. Editorial Médica Panamericana: México City, 2004, pp 246–260.

3. Ruiz-Argüelles GJ, López-Martínez B, Ramírez-Cabrera JM, Reyes-Nuñez V, Rodríguez-Cedeño H, Garcés-Eisele J . Molecular monitoring of the treatment of patients with BCR/ABL(+) chronic myelogenous leukemia. Rev Invest Clín Méx 2001; 53: 235–239.

4. Or R, Shapira MY, Resnick I, Amar A, Ackerstein A, Samuel S et al. Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood 2003; 101: 441–445.

5. Ruiz-Argüelles GJ, Gómez-Almaguer D, López-Martínez B, Cantú-Rodríguez OG, Jaime-Pérez JC, González-Llano O . Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia. Haematologica 2002; 87: 894–896.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update in Childhood Chronic Myeloid Leukemia;Hemato;2022-11-05

2. The influence of drug prices, new availability of inexpensive generic imatinib, new approvals, and post-marketing research on the treatment of chronic myeloid leukaemia in the USA;The Lancet Haematology;2022-11

3. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring;American Journal of Hematology;2022-07-06

4. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring;American Journal of Hematology;2020-04-10

5. Outcome of Imatinib Treatment in Yemeni Patients With Chronic Myeloid Leukemia and the Influence of Nonadherence to Treatment and Duration of Previous Hydroxyurea Therapy;Clinical Lymphoma Myeloma and Leukemia;2020-03